NOTICES 
33167 
lie acid segment associated with messenger 
ribonucleic acid in mouse sarcoma 180 as- 
cites cells. Biochemistry 11, 792-798. 
Moore, P. B. (1966) Methylation of mes- 
senger RNA in Escherichia coli. J. Mol. Biol. 
18, 38-47. 
Morrison, T., Stampfer, M., Baltimore, D. 
and Lodish, H. F. (1974) Translation of ve- 
sicular stomatitis messenger RNA by ex- 
tracts from mammalian and plant cells. J. 
Virol. 13, 62-72. 
Moss, B. and Koczot, F. (1976) Sequence 
of methylated nucleotides at the 5'-terminus 
of adenovirus-specific RNA. J. Virol. 1 7, 285- 
392. 
Mudd, J. A. and Summers, D. F. (1970) Po- 
lysomal ribonucleic acid of vesicular stoma- 
titis virus-infected HeLa cells. Virology 42, 
958-968. 
Padgett, B. L. and Walker, D. L. (1973) 
Prevalence of antibodies in human sera 
against JC virus, an isolate from a case of 
progressive multifocal leukoencephalo- 
pathy. J. Inf. Dis. 127, 467-470. 
Perry, R. P. and Scherrer, K. (1975) The 
methylated constituents of globin mRNA 
FEBS Letter 57, 73-78. 
Philipson, L„ Wall, R., Glickman, G. and 
Darnell, J. E. (1971) Addition of polyadeny- 
late sequences to virus-specific RNA during 
adenovirus replication. Proc. Nat. Acad. Sci. 
USA 68, 2806-2809. 
Pridgen, C. and Kingsbury, D. W. (1972) 
Adenylate-rich sequences in Sendai virus 
transcripts from infected cells. J. Virol. 10, 
314-317. 
Rekosh, D. M., Lodish, H. F„ and Balti- 
more, D. (1970) Protein synthesis in Escheri- 
chia coli extracts programmed by poliovirus 
RNA. J. Mol. Biol. 54, 327-340. 
Seheid, A. and Choppin, P. W. (1974) Iden- 
tification of biological activities of paramyx- 
ovirus glycoproteins. Activation of cell 
fusion, hemolysis, and infectivity by proteo- 
lytic cleavage of an inactive precursor pro- 
tein of Sendai virus. Virology, 57, 475-490. 
Shah, K., Daniel, R. and Warszawski, R. 
(1973) High prevalence of antibodies to BK 
virus, an SV40-related papovavirus, in resi- 
dents of Maryland. J. Inf. Dis. 128, 784-787. 
Shah, K. and Nathanson, N. (1976) 
Human exposure to SV40: Review and com- 
ment. Am. J. Epidem. 103, 1-12. 
Shine, J. and Dalgamo, L. (1974) the 3- 
terminal sequence of Escherichia coli 16S ri- 
bosomal RNA: Complementarity to non- 
sense triplets and ribosome binding sites. 
Proc. Nat. Acad. Sci. USA 71, 1342-1346. 
Sjogren, H. O. (1964) Studies on specific 
transplantation resistance to polyoma-virus- 
induced tumors. III. Transplantation resis- 
tance to genetically compatible polyoma 
tumors induced by polyoma homografts. J. 
Nat. Cancer Inst. 32, 645-659. 
Sjogren, H. O., Minowada, J. and Ankerst, 
J. (1967) Specific transplantation antigens 
of mouse sarcomas induced by adenovirus 
type 12. J. Exp. Med. 125, 689-701. 
Sol, C. J. A. and van der Noordaa, J. (1977) 
Oncogenicity of SV40 DNA in the Syrian 
hamster. J. Gen. Virol. 37, 635-638. 
Stavis.. R. and August, J. T. (1970) The 
biochemistry of RNA bacteriophage replica- 
tion. Ann. Rev. of Biochem. 39, 527-560. 
Steitz, J. A. and Jakes, K. (1975) How ribo- 
somes select initiator regions in mRNA: 
Base pair formation between the 3' termi- 
nus of 16S rRNA and the mRNA during ini- 
tiation of protein synthesis in Escherichia 
coli. Proc. Nat. Acad. Sci. USA 72, 4734- 
4738. 
Szilagyi, J. F. and Pringle, C. R. (1972) 
Effect of temperature-sensitive mutations 
on the virion associated RNA transcriptase 
of vesicular stomatitis virus. J. Mol. Biol. 71, 
281-291. 
Wagner, R. W. (1975) Reproduction of 
Rhabdo viruses. Comprehensive Virology, 
vol. 4, Fraenkel-Conrat, H. and Wagner, R. 
R. eds, p.2. 
Wei, C. M. and Moss, B. (1975) Methylated 
nucleotides block 5 -terminus of vaccinia 
virus messenger RNA. Proc. Nat. Acad. Sci. 
USA 72, 318-322. 
Weinberg, R. A., Ben-Ishai, Z. and New- 
bold, J. E. (1972) Poly A associated with 
SV40 messenger RNA. Nature New Biol. 
238, 111-113. 
Weiss, S. R. and Bratt, M. A. (1976) Com- 
parative electrophoresis of the 18-22S RNAs 
of Newcastle Disease Virus. J. Virol. 18, 316- 
323. 
Wold, W S. M.. Mackey, J. K., Brack- 
mann, K. H., Takemori, N„ Rigden, P., and 
Green, M. (1978) Analysis of human tumors 
and human malignant cell lines for BK 
virus-specific DNA sequences. Proc. Nat. 
Acad. Sci. USA 75, 454-458. 
COMMITTEE MEMBERS! U.S. 
Dr. Bruce W. Calnek, Chairman, Depart- 
ment of Avian and Aquatic Animal Medi- 
cine, New York State College of Veteri- 
nary Medicine, Cornell University, Ithaca, 
N.Y. 14853. 
Dr. Purnell W. Choppin, Rockefeller Uni- 
versity, 1230 York Ave., New York, N.Y. 
10021. 
Dr. Walter R. Dowdle, Director, Virology 
Division, Bureau of Laboratories, Center 
for Disease Control, Atlanta, Ga. 30333. 
Dr. Bernard N. Fields, Professor of Microbi- 
ology and Molecular Genetics, Harvard 
Medical School, Boston, Mass. 02115. 
Dr. Harold S. Ginsberg, Chairman, Depart- 
ment of Microbiology, College of Physi- 
cians and Surgeons, Columbia University 
(on Sabbatical at Rockefeller University), 
1230 York Ave. New York, N.Y. 10021. 
Dr. Robert Haselkorn, Chairman, Depart- 
ment of Biophysics and Theoretical Biol- 
ogy, University of Chicago, Chicago, 111. 
60637. 
Dr. Edwin H. Lennette, Chief, Biomedical 
Laboratories, California State Department 
of Health, 2151 Berkeley Way, Berkeley, 
Calif. 94707. 
Dr. Malcolm A. Martin, Head, Physical Bio- 
chemistry Section, Laboratory of Biology 
of Viruses, NLAID, National Institutes of 
Health, Bethesda, Md. 20014. 
Dr. Thomas C. Merigan, Professor, Depart- 
ment of Medicine, School of Medicine, Di- 
vision of Infectious Diseases, Stanford 
University, Stanford, Calif. 94305. 
Dr. Wallace P. Rowe, Chief, Laboratory of 
Viral Diseases, NIAID, National Institutes 
of Health, Bethesda, Md. 20014. 
Dr. Joe Sambrook, Cold Spring Harbor Lab- 
oratory, P.O. Box 100, Cold Spring, 
Harbor, N.Y. 11724. 
Dr. Max Summers, Professor, Entomology 
Department, Texas A. & M. University, 
College Station, Tex. 77843. 
Dr. Robert R. Wagner, Chairman, Depart- 
ment of Microbiology, University of Vir- 
ginia School of Medicine, Charlottesville, 
Va. 22901. 
NIAID STAFF 
Dr. Richard M. Krause, Director, National 
Institute of Allergy and Infectious Dis- 
eases, National Institutes of Health, Be- 
thesda, Md. 20014. 
Dr. John B. Brooksby, The Animal Virus 
Research Institute, Pirbright, Woking. 
Surrey GU 24 ONF, England. 
Dr. Mike Fried, Imperial Cancer Research 
Fund Laboratories. Lincoln's Inn Fields. 
London, WC2A 3PX, England. 
Professor Harald zur Hausen, Institut fur 
Virologie, Zentrum fur Hygiene, Her- 
mann-Herder-Str. 11. 78 Freiburg, Federal 
Republic of Germany. 
Professor Leon Hirth, Institut de Botani- 
que, 15. rue Rene Descartes. 67 Stras- 
bourg, France. 
Dr. Roger Hull, John Innes Institute, 
Colney Lane, Norwich, England. 
Dr. Leevi Kaariaien, Department of Viro- 
logy, University of Helsinki, Haartmanin- 
katu 3, Helsinki 29, Finland. 
Dr. Helio G. Pereira, The Animal Virus Re- 
search Institute, Pirbright, Woking, 
Surrey GU 24 ONF, England. 
Professor Lennart Philipson, University of 
Uppsala, Eiomedical Center, Department 
of Microbiology, Box 581, 751 23 Uppsala, 
Sweden. 
Dr. Heinz L. Sanger, Arbeitsgruppe Pflan- 
zenvirologie, Justus-Liebig-Universitat, 
Frankfurter Str. 107, 63 Giessen, Federal 
Republic of Germany. 
Dr. John Tooze, European Molecular Biol- 
ogy Organization, Postfach 1022.40, 69 
Heidelberg, Federal Republic of Germany. 
Dr. David A. J. Tyrrell, Clinical Research 
Center, Watford Rd., Harrow, Middlesex, 
England. 
Dr. Robin Weiss, Imperial Cancer Research 
Fund Laboratories, P.O. Box 123, Lin- 
coln’s Inn Fields, London, WC2A 3PX, 
England. 
Professor Charles Weissmann, Institut fur 
Molekularbiologie I, Universitat Zurich, 
Honggerberg, 8049 Zurich, Switzerland. 
Appendix F.— Report of the Virus 
Working Group Sponsored by the 
Recombinant DNA Advisory Com- 
mittee 
On April 6-7, 1978, a working group 
of American virologists met in a public 
meeting at the National Institutes of 
Health to' (1) Review the report of the 
U.S.-EMBO workshop to assess risks 
for recombinant DNA expriments in- 
volving the genomes of animal, plant, 
and insect vectors and (2) Translate 
the conclusions of the U.S.-EMBO 
report into recommended physical and 
bilogical containment levels for consid- 
eration by the RAC for incorporation 
into the revised NIH guidelines for re- 
combinant DNA research. The 19 sci- 
entists in attendance (see attached 
roster) had expertise in clinical infec- 
tious disease; epidemiology of viral dis- 
ease; medical and diagnostic virology; 
the biology of virus infection; bio- 
chemical virology; viral immunology; 
and plant, insect, and veterinary vir- 
uses. Six of the participants (Drs. 
Ginsberg, Choppin, Martin, Rowe, 
Summers, and Wagner) had attended 
the U.S.-EMBO workshop. 
FEDERAL REGISTER, VOL. 43, NO. 146— FRIDAY, JULY 28, 1978 
[ 128 ] 
